Perceived impact of discussions with a healthcare professional on patients' decision regarding COVID-19 vaccine
Alric CharmassonMarie EcollanPhilippe JauryHenri PartoucheAdèle FrachonJuliette Pinota Department of General Practice,Université Paris Cité,Paris,Franceb INSERM,IAME,Université Paris Cité and Université Sorbonne Paris Nord,Paris,France
DOI: https://doi.org/10.1080/21645515.2024.2307735
2024-02-14
Human Vaccines & Immunotherapeutics
Abstract:There is evidence that advice from Healthcare Professionals (HCPs) plays an important role in patients' decision to get vaccinated, but the extent to which patients perceive this impact is unclear. The aim of this study was to assess the perceived impact of a discussion with a HCP on participants' decision to be vaccinated against COVID-19. A cross-sectional survey was conducted among adults who consulted a general practitioner (GP) or a pharmacist in Ile-de-France, France, after COVID-19 vaccines became available (October-November 2021 period). A total of 344 participants were included, 65.2% of whom reported having had a discussion about COVID-19 vaccines with a HCP. Overall, 55% of participants were advised to be vaccinated by their HCP. Most of the discussions took place with a GP ( n = 203, 48.9%). According to 52.5% of participants, the discussion had a positive impact, i.e. it was perceived as encouraging vaccination. The latter reported that, among HCPs, GPs had the greatest number of discussions with a positive impact on the decision to be vaccinated against COVID-19 (93.1%). In the study population, the COVID-19 vaccine hesitancy rate, according to the WHO definition, was high (38.1%), although the COVID-19 vaccine coverage rate was 87.1%. Vaccine hesitant participants were more likely to report a discussion that had a perceived negative impact on their decision to get vaccinated (20.0%) than non-hesitant participants (5.8%, p = .004).
immunology,biotechnology & applied microbiology